Thyroid hormone and androgen signals mutually interplay and enhance inflammation and tumorigenic activation of tumor microenvironment in prostate cancer.

[1]  T. Troiani,et al.  Thyroid Hormone Enhances Angiogenesis and the Warburg Effect in Squamous Cell Carcinomas , 2021, Cancers.

[2]  O. de Cobelli,et al.  BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored , 2021, Diagnostics.

[3]  L. Insabato,et al.  Periprostatic adipose tissue promotes prostate cancer resistance to docetaxel by paracrine IGF‐1 upregulation of TUBB2B beta‐tubulin isoform , 2021, The Prostate.

[4]  E. Di Cicco,et al.  Thyroid hormone action in epidermal development and homeostasis and its implications in the pathophysiology of the skin , 2021, Journal of Endocrinological Investigation.

[5]  M. Dattani,et al.  Germ Line Mutations in the Thyroid Hormone Receptor Alpha Gene Predispose to Cutaneous Tags and Melanocytic Nevi , 2021, Thyroid : official journal of the American Thyroid Association.

[6]  G. Sonpavde,et al.  First-line systemic therapy for metastatic castration-sensitive prostate cancer: an updated systematic review with novel findings. , 2020, Critical reviews in oncology/hematology.

[7]  C. J. Roberts,et al.  Thyroid and androgen receptor signaling are antagonized by μ‐Crystallin in prostate cancer , 2020, International journal of cancer.

[8]  M. Boccellino,et al.  The Crosstalk between Prostate Cancer and Microbiota Inflammation: Nutraceutical Products Are Useful to Balance This Interplay? , 2020, Nutrients.

[9]  A. Baniahmad,et al.  Thyroid hormone induces cellular senescence in prostate cancer cells through induction of DEC1 , 2020, The Journal of Steroid Biochemistry and Molecular Biology.

[10]  M. Stornaiuolo,et al.  The NANOG Transcription Factor Induces Type 2 Deiodinase Expression and Regulates the Intracellular Activation of Thyroid Hormone in Keratinocyte Carcinomas , 2020, Cancers.

[11]  G. Perruolo,et al.  The thyroid hormone inactivator enzyme, Type 3 deiodinase, is essential for coordination of keratinocyte growth and differentiation. , 2020, Thyroid : official journal of the American Thyroid Association.

[12]  S. Staibano,et al.  Thyroid hormone induces progression and invasiveness of squamous cell carcinomas by promoting a ZEB-1/E-cadherin switch , 2019, Nature Communications.

[13]  M. Dentice,et al.  Deiodinases and their intricate role in thyroid hormone homeostasis , 2019, Nature Reviews Endocrinology.

[14]  D. Banerjee,et al.  Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment , 2019, Cancers.

[15]  I. Mills,et al.  The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance , 2019, Oncogene.

[16]  R. Beyaert,et al.  Inflammation and NF-κB Signaling in Prostate Cancer: Mechanisms and Clinical Implications , 2018, Cells.

[17]  C. Crews,et al.  Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance , 2018, Communications Biology.

[18]  W. Syn,et al.  Thyroid hormone in the regulation of hepatocellular carcinoma and its microenvironment. , 2018, Cancer letters.

[19]  S. Staibano,et al.  The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells , 2017, Oncotarget.

[20]  Zhenggang Zhu,et al.  IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway , 2017, Oncotarget.

[21]  R. Hill,et al.  CANCER-ASSOCIATED FIBROBLAST EXOSOMES REGULATE SURVIVAL AND PROLIFERATION OF PANCREATIC CANCER CELLS , 2016, Oncogene.

[22]  H. Klocker,et al.  Cancer-Associated Fibroblasts Modify the Response of Prostate Cancer Cells to Androgen and Anti-Androgens in Three-Dimensional Spheroid Culture , 2016, International journal of molecular sciences.

[23]  C. Aceves,et al.  Triiodothyronine Attenuates Prostate Cancer Progression Mediated by β-Adrenergic Stimulation , 2016, Molecular medicine.

[24]  M. V. Vander Heiden,et al.  The Role of Pyruvate Kinase M2 in Cancer Metabolism , 2015, Brain pathology.

[25]  G. Kaltsas,et al.  Immune System Effects on the Endocrine System , 2015 .

[26]  A. Bianco,et al.  Thyroid hormone signaling in energy homeostasis and energy metabolism , 2014, Annals of the New York Academy of Sciences.

[27]  Jie Li,et al.  PKM2 Isoform-Specific Deletion Reveals a Differential Requirement for Pyruvate Kinase in Tumor Cells , 2013, Cell.

[28]  D. Führer,et al.  Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective. , 2013, Endocrine-related cancer.

[29]  D. Albanes,et al.  Circulating Thyroxine, Thyroid-Stimulating Hormone, and Hypothyroid Status and the Risk of Prostate Cancer , 2012, PloS one.

[30]  P. Larsen,et al.  β-Catenin regulates deiodinase levels and thyroid hormone signaling in colon cancer cells. , 2012, Gastroenterology.

[31]  F. B. Davis,et al.  Thyroid hormones as modulators of immune activities at the cellular level. , 2011, Thyroid : official journal of the American Thyroid Association.

[32]  H. Kung,et al.  Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells. , 2010, Cancer research.

[33]  L. Vatten,et al.  Thyroid Function and Cancer Risk: A Prospective Population Study , 2009, Cancer Epidemiology Biomarkers & Prevention.

[34]  P. Larsen,et al.  Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes , 2007, Proceedings of the National Academy of Sciences.

[35]  Z. Qiu,et al.  A Prospective Study of Iodine Status, Thyroid Function, and Prostate Cancer Risk: Follow-up of the First National Health and Nutrition Examination Survey , 2007, Nutrition and cancer.

[36]  R. Versteeg,et al.  Regulation of type III iodothyronine deiodinase expression in human cell lines. , 2006, Endocrinology.

[37]  J. Klein.  The Immune System as a Regulator of Thyroid Hormone Activity , 2006, Experimental biology and medicine.

[38]  N. Fusenig,et al.  Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells. , 2002, Differentiation; research in biological diversity.

[39]  R. Stock,et al.  Serum triiodothyronine is increased in men with prostate cancer and benign prostatic hyperplasia. , 2002, The Journal of urology.

[40]  S. Ho,et al.  Clinical review 134: The endocrinology of prostate cancer. , 2001, The Journal of clinical endocrinology and metabolism.

[41]  R. Kornreich,et al.  Association between serum triiodothyronine (t3) level and risk of disease recurrence in men with localized prostate cancer , 2001, Prostate Cancer and Prostatic Diseases.

[42]  J. Harney,et al.  Substrate-induced down-regulation of human type 2 deiodinase (hD2) is mediated through proteasomal degradation and requires interaction with the enzyme's active center. , 2000, Endocrinology.

[43]  P. Kopp,et al.  The Thyroid Hormone Receptor Variant α2 Is a Weak Antagonist because It Is Deficient in Interactions with Nuclear Receptor Corepressors. , 1998, Endocrinology.